Counting of co-exposure
In this qualitative approach, the number of combinations of substances to which an individual is exposed are recorded, see Table 109. There is no cut-off level, the only criterion is the presence of a substance in the simulated daily diet or not. For an acute or short term exposure assessment, a simulated individual day is the smallest entity to determine co-exposure. For a chronic or long term exposure assessment, co-exposures are summarized at the individual level, e.g. co-exposure is determined combining all consumption days of an individual.
Substance  | 
day 1  | 
day 2  | 
day 3  | 
…  | 
day n  | 
|---|---|---|---|---|---|
Tebuconazole  | 
x  | 
x  | 
…  | 
||
Bitertanol  | 
x  | 
x  | 
…  | 
x  | 
|
Triadimefon  | 
x  | 
…  | 
…  | 
x  | 
|
…  | 
…  | 
…  | 
…  | 
…  | 
…  | 
In Table 110, the frequency and percentage for the number of substances occurring together are shown.
Number of substances  | 
Frequency  | 
Percentage  | 
|---|---|---|
0  | 
337  | 
3.4  | 
1  | 
959  | 
9.6  | 
2  | 
1207  | 
12.1  | 
3  | 
1275  | 
12.8  | 
…  | 
…  | 
…  | 
In Table 111, the mixtures containing the substance(s) including all other combinations with the specified combination of substance(s), (a maximum number of 15 records is shown).
Number of substances  | 
Percentage  | 
Substances  | 
|---|---|---|
1  | 
5.88  | 
Tebuconazole  | 
2  | 
3.88  | 
Imazalil (aka enilconazole), Tebuconazole  | 
0  | 
3.37  | 
|
3  | 
2.20  | 
Difenoconazole, Imazalil (aka enilconazole), Tebuconazole  | 
1  | 
1.78  | 
Imazalil (aka enilconazole)  | 
3  | 
1.76  | 
Imazalil (aka enilconazole), Tebuconazole, Triadimenol  | 
…  | 
…  | 
…  |